Polymorphism in the Interleukin-10 Promoter Affects Both Provirus Load and the Risk of Human T Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis

To investigate non-human leukocyte antigen candidate genes that influence the outcome of human T cell lymphotropic virus (HTLV) type I infection, we analyzed 6 single-nucleotide polymorphisms in the interleukin (IL)-10 promoter region in 280 patients with HTLV-I-associated myelopathy/tropical spasti...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 190; no. 7; pp. 1279 - 1285
Main Authors Sabouri, Amir H., Saito, Mineki, Lloyd, Alun L., Vine, Alison M., Witkover, Aviva W., Furukawa, Yoshitaka, Izumo, Shuji, Arimura, Kimiyoshi, Marshall, Sara E. F., Usuku, Koichiro, Bangham, Charles R. M., Osame, Mitsuhiro
Format Journal Article
LanguageEnglish
Published Chicago, IL The University of Chicago Press 01.10.2004
University of Chicago Press
Oxford University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To investigate non-human leukocyte antigen candidate genes that influence the outcome of human T cell lymphotropic virus (HTLV) type I infection, we analyzed 6 single-nucleotide polymorphisms in the interleukin (IL)-10 promoter region in 280 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis(HAM/ TSP) and 255 HTLV-I-seropositive asymptomatic carriers from an area where HTLV-I is endemic. The IL-10 −592 A allele, which shows lower HTLV-I Tax-induced transcriptional activity than the C allele in the Jurkat T cell line, was associated with a >2-fold reduction in the odds of developing HAM/TSP (P = .011; odds ratio [OR], 0.50 [95% confidence interval, 0.30–0.86]) by reducing the provirus load in the whole cohort (P = .009, analysis of variance). Given the OR and the observed frequency of IL-10 −592 A, we demonstrate that this allele prevents ∼44.7% (standard deviation, ±13.1%) of potential cases of HAM/TSP, which indicates that it defines one component of the genetic susceptibility to HAM/TSP in the cohort.
Bibliography:istex:3921B6EA67614A2D4A5CA79E92A0D48DEA2C779C
ark:/67375/HXZ-NQTHV6BF-H
Present affiliation: Department of Immunology, Imperial College, London, United Kingdom.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0022-1899
1537-6613
DOI:10.1086/423942